focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNSF.L Regulatory News (NSF)

  • There is currently no data for NSF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

23 Feb 2021 07:00

RNS Number : 9602P
Non-Standard Finance PLC
23 February 2021
 

Non-Standard Finance plc

('NSF', the 'Company' or the 'Group')

23 February 2021

 

Trading update

The Board of Non-Standard Finance has this morning issued the following trading update. The audit of our 2020 results is now underway and the information given below is unaudited, pending the completion of the audit process.

Branch-based lending - Whilst there was a strong pick-up in loan volume during August, September and October 2020 with new cash issued running at c.£10 million per month that stabilised the loan book, the subsequent tiered lockdowns, which were particularly severe in our customer heartland, reduced lending volumes in November and December. As a result, the net loan book at 31 December 2020 was c.20% lower than at the end of 2019. Whilst a consequence of the COVID-19 pandemic has been a significant increase in impairment and provisions, it has been most encouraging that the loans written since the start of the pandemic have performed better than our historical average and in the second half of 2020 we also saw an improvement in the collection performance of the COVID-flagged book. This robust performance of new lending illustrates the strength of our face-to-face lending model and augurs well for a return to strong sector growth once the economy begins to open up again. 

Home credit - Loans at Home also experienced a significant uplift in loan volume during the second half of 2020 with new cash issued running at c.£5m per month. Although growth in lending volume continued in November and December due to the normal seasonal pattern, this was down by a third versus 2019 as a result of the tiered lockdowns and the closure of retail in December 2020. Collections improved on the whole loan book in the second half and the number of COVID-19 flagged customers had reduced to less than 1% at the year-end with the result that impairment as a percentage of revenue in 2020 was significantly lower than in 2019. This strong collections performance, in conjunction with lower lending meant that the net loan book ended the year down by a third versus 2019. We expect to see a significant increase in demand once the economy is opened up as our customers resume their normal lifestyle. There may also be opportunities to take advantage of some competitors contracting their business in this sector.

Guarantor loans - Following the FCA's review of the Group's guarantor loans division as part of a wider review of the guarantor loan sector, resulting in a £16m provision for redress announced in our 2020 half year results, lending volumes were minimal in the second half of 2020. Economically, the younger customer base has been harder hit by the pandemic than our other two divisions and calls on guarantors have been constrained due to the pandemic, resulting in a marked increase in impairment. Collections nevertheless remained robust during the second half of 2020 with the result that the net loan book reduced by c.40% versus the prior year. We are working hard on the redress methodology and hope to have concluded the process with the FCA early in the second quarter.

Group - Branch-based lending and home credit delivered a solid trading performance during the second half of 2020 in what were extremely challenging circumstances and overall, the Group's combined net loan book declined by c.27% versus the previous year.

Liquidity and funding

The Group has continued to operate within its financial covenants. The combination of lower levels of lending with a solid collections performance meant that as at 31 December, 2020 cash at bank had increased to £78m and gross borrowings were £330m.

Capital raise

The Group now needs to strengthen the balance sheet by raising sufficient new equity capital to support future growth, avoid future covenant breaches and to address the material uncertainties regarding going concern. The Board has therefore commenced work on a substantial capital raise with the support of Alchemy, its largest shareholder with a view to completing this in the second quarter of 2021. Once completed, the Group will be in a strong position to take advantage of what it believes to be an exceptional market opportunity in the non-standard sector.

 

For more information:

 

Non-Standard Finance plc

Peter Reynolds, Director, IR and Communications

 

+44 (0) 20 3869 9020

 

Maitland/AMO

Neil Bennett

Andy Donald

Finlay Donaldson

 

+44 (0) 20 7379 5151

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUURRRAAUUUUR
Date   Source Headline
10th Jul 20237:00 amRNSNotice of Delisting
7th Jul 20238:06 amRNSSuspension of Trading in Ordinary Shares
5th Jul 20233:18 pmRNSUpdate on Delisting and Suspension of Shares
23rd Jun 20232:51 pmRNSFiling of Annual General Meeting Resolutions
23rd Jun 20232:49 pmRNSResult of AGM
23rd Jun 20237:00 amRNSUpdate on Scheme, Delisting & Directorate Change
23rd May 20237:00 amRNSStandard form for notification of major holdings
18th May 20237:00 amRNSProposed Recapitalisation & Directorate Change 
28th Apr 20235:51 pmRNSReplacement: Update on scheme of arrangement
28th Apr 20233:33 pmRNSUpdate on scheme of arrangement
28th Apr 20238:21 amRNSAudited full year results to 31 December 2022
14th Apr 20237:00 amRNSProposed Release of Debt and Directorate Change
4th Apr 20234:14 pmRNSDirector/PDMR Shareholding
29th Mar 20234:35 pmRNSPrice Monitoring Extension
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20237:39 amRNSLaunch of Scheme & Proposed Recapitalisation
17th Mar 20237:00 amRNSScheme of Launch & Proposed Recapitalisation
13th Feb 20237:00 amRNS2022 Trading Statement
4th Jan 202310:15 amRNSDirector/PDMR Shareholding
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:35 pmRNSPrice Monitoring Extension
29th Sep 20225:50 pmRNSDirector/PDMR Shareholding
29th Sep 20224:40 pmRNSSecond Price Monitoring Extn
29th Sep 20224:37 pmRNSPrice Monitoring Extension
28th Sep 20227:05 amRNSUpdate on Current Status and Regulatory matters
28th Sep 20227:05 amRNSUnaudited Half Year Results to 30 June 2022
27th Jul 20224:41 pmRNSSecond Price Monitoring Extn
27th Jul 20224:36 pmRNSPrice Monitoring Extension
22nd Jul 20224:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20224:35 pmRNSPrice Monitoring Extension
19th Jul 20224:41 pmRNSSecond Price Monitoring Extn
19th Jul 20224:35 pmRNSPrice Monitoring Extension
6th Jul 20224:40 pmRNSSecond Price Monitoring Extn
6th Jul 20224:36 pmRNSPrice Monitoring Extension
4th Jul 20224:16 pmRNSDirector/PDMR Shareholding
15th Jun 20223:25 pmRNSFunding facilities update
26th May 20224:42 pmRNSFilings of AGM Resolutions
26th May 20222:49 pmRNSResults of Annual General Meeting
29th Apr 202212:00 pmRNSDirectorate Change
29th Apr 20227:00 amRNSAudited full year results to 31 December 2021
29th Apr 20227:00 amRNSAudited full year results to 31 December 2021
1st Apr 20224:40 pmRNSSecond Price Monitoring Extn
1st Apr 20224:35 pmRNSPrice Monitoring Extension
29th Mar 20229:26 amRNSDirector/PDMR Shareholding
17th Mar 20224:41 pmRNSSecond Price Monitoring Extn
17th Mar 20224:36 pmRNSPrice Monitoring Extension
16th Mar 20224:41 pmRNSSecond Price Monitoring Extn
16th Mar 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.